2024

1. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma

   Journal of Neuro-Oncology, Vol. 166, Núm. 3, pp. 407-415

2. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy: the Spanish registry

   Blood

3. Analysis of the reasons for requesting HIV serology in the emergency department other than those defined in the targeted screening strategy of the “Urgències VIHgila” program and its potential inclusion in a future consensus document

   Enfermedades Infecciosas y Microbiologia Clinica

4. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

   Journal of Endocrinological Investigation

5. Cardiovascular considerations on recreational scuba diving. SEC-Clinical Cardiology Association/SEC-Working Group on Sports Cardiology consensus document

   Revista Espanola de Cardiologia

6. Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy

   npj Breast Cancer, Vol. 10, Núm. 1

7. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)

   Open Forum Infectious Diseases, Vol. 11, Núm. 3

8. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

   mSphere, Vol. 9, Núm. 3

9. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

   Neurologia, Vol. 39, Núm. 2, pp. 196-208

10. Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Journal of Neuro-Oncology, (2024), 166, 3, (407-415), 10.1007/s11060-023-04513-1)

    Journal of Neuro-Oncology

11. Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2647-2664), 10.1007/s12094-023-03215-4)

    Clinical and Translational Oncology

12. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

13. Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

    Environment International, Vol. 186

14. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

15. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

    International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511

16. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

17. Everyone was Fooled, it Burns: Simple Diy Proof of the Falsity of Heat-Not-Burn Tobacco

    Archivos de Bronconeumologia

18. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

    Journal of neurology, Vol. 271, Núm. 1, pp. 472-485

19. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas

20. External validation of the 0/1h-algorithm and derivation of a 0/2h-algorithm using a new point-of-care Hs-cTnI assay

    American Heart Journal, Vol. 268, pp. 104-113